Description du projet
La voie vers de meilleurs résultats pour les patients et les soignants
La principale priorité des soins contre le cancer est de traiter la tumeur. Cependant, il est tout aussi important de traiter et de soigner le patient. Une approche des soins centrée sur le patient par la collecte systématique de ses résultats, le traitement des symptômes et l’amélioration des fonctions devrait faire partie intégrante des soins oncologiques standard. Le projet MyPath, financé par l’UE, intégrera les soins centrés sur le patient aux soins courants du cancer en développant et en mettant en œuvre une solution numérique innovante qui facilite la communication entre les patients, les prestataires de soins et les soignants. Les parcours de soins centrés sur le patient de MyPath, renforcés par la technologie et fondés sur des preuves, amélioreront considérablement la qualité et l’accès aux traitements et aux soins, réduiront les variations dans la pratique clinique et optimiseront les ressources dans différents contextes de soins du cancer. Cela permettra de réduire la charge émotionnelle et économique liée au cancer.
Objectif
In the EU, 2.7M people were diagnosed with and 1.3M died of cancer in 2020. Over 12M people have survived cancer, thanks to advances in early detection and new therapies. With higher cure rates and more patients living longer with cancer, access to patient-centred care consisting of optimal supportive, palliative, survivorship and end-of-life care becomes increasingly important. However, cancer care still has silos, and to this day, there is no technical support available that is suitable for different cultures, settings and environments.
Several randomised controlled trials have provided evidence that the integration of patient-centred care in standard oncology care results in better patient and caregiver outcomes. As yet, these findings have not translated into clinical routine.
In this project, we will develop technology-enhanced and evidence-based patient-centred care pathways, called MyPath, to be merged with tumour-centred treatments across supportive, palliative, survivorship and end-of-life care. MyPath integrates patient-reported outcomes of the OUS Eir software, to be further advanced with contributions of renowned European oncologists, ethicists, psychologists and sociologists. It will be configurated on the eHealth platform of our SME partner DNV Imatis. Its effectiveness and sustainability will be assessed in an implementation science study in 9 clinical centres across Europe. With the support of leading cancer care professional associations ESMO and EAPC, and the cancer patient organisation ECPC, we are committed to delivering the right care to the right person at the right time by the right persons.
We hypothesise that MyPath can significantly improve the quality of and access to treatment and care, reduce variations in clinical practice, and optimise resources in family, community, and hospital care settings. This will ultimately reduce the physical, emotional, and ultimately economic burden linked to cancer.
Champ scientifique
Mots‑clés
Programme(s)
Régime de financement
HORIZON-RIA - HORIZON Research and Innovation ActionsCoordinateur
0450 Oslo
Norvège